Live Breaking News & Updates on Recruitment Started

Stay updated with breaking news from Recruitment started. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Filing expected this Q3 for NASDAQ Company's JW-100 treatment for Eczema

FDA Filing expected this Q3 for NASDAQ Company's JW-100 treatment for Eczema
briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.

United States , Rich Miller , Phillip Fleck , Company Investigational New Drug , Clinical Studies Underway On Company Proprietary Products , Jupiter Wellness Inc , Drug Administration , Multi Billion Dollar Skin Care , Clinical Studies Underway , Acquire Company , Qualified Management , Extensive Accomplishments , Theme Park Business Sees Surge , Recent Business , Clinical Pipeline , Patient Enrollment , Skin Cancer , Recruitment Started , First Degree Burns , Eczema Phase , Investigational New Drug , Support Growth , Based Pharma , Chief Compliance Officer , Sees Significant Monthly Sales Growth , Global Theme Parks Set ,

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments
ACCESSWIRE
Four Indications in Clinical Development
JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced an update on its clinical pipeline of CBD-based therapeutic topical formulations including JW-100 for the treatment of eczema, JW-200 for skin cancer, JW-300 for burns, and JW-400 for herpes cold sores.
Commenced Patient Enrollment for Skin Cancer: Study Completion Expected Q4 2021
Jupiter s JW-200 is designed to provide action and relief in the treatment of Actinic Keratosis (AK), the most common precancer that forms on skin as a result of exposure to ultraviolet (UV) rays. The objective of this double blinded, placebo-controlled study is to evaluate the efficacy of JW-200 in both the treatment and prevention of disease, with a primary efficacy en ....

United States , Brian John , Indications In Clinical Development , Skin Cancer Foundation , Company Investigational New Drug , Jupiter Wellness Inc , Drug Administration , Four Indications , Clinical Development , Jupiter Wellness , Patient Enrollment , Skin Cancer , Actinic Keratosis , Recruitment Started , First Degree Burns , Eczema Phase , Investigational New Drug , Herpes Cold Sores Expected , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , பிரையன் ஜான் , தோல் புற்றுநோய் அடித்தளம் , வியாழன் ஆரோக்கியம் இன்க் , மருத்துவ வளர்ச்சி , வியாழன் ஆரோக்கியம் , நோயாளி சேர்க்கை ,

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

United States , Brian John , Indications In Clinical Development , Skin Cancer Foundation , Company Investigational New Drug , Jupiter Wellness Inc , Drug Administration , Four Indications , Clinical Development , Jupiter Wellness , Patient Enrollment , Skin Cancer , Actinic Keratosis , Recruitment Started , First Degree Burns , Eczema Phase , Investigational New Drug , Herpes Cold Sores Expected , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , பிரையன் ஜான் , தோல் புற்றுநோய் அடித்தளம் , வியாழன் ஆரோக்கியம் இன்க் , மருத்துவ வளர்ச்சி , வியாழன் ஆரோக்கியம் , நோயாளி சேர்க்கை ,

Jupiter Wellness, Inc.: Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments

Jupiter Wellness, Inc.: Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments
Four Indications in Clinical Development
JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced an update on its clinical pipeline of CBD-based therapeutic topical formulations including JW-100 for the treatment of eczema, JW-200 for skin cancer, JW-300 for burns, and JW-400 for herpes cold sores.
Commenced Patient Enrollment for Skin Cancer: Study Completion Expected Q4 2021
Jupiter s JW-200 is designed to provide action and relief in the treatment of Actinic Keratosis (AK), the most common precancer that forms on skin as a result of exposure to ultraviolet (UV) rays. The objective of this double blinded, placebo-controlled study is to evaluate the efficacy of JW-200 in both the treatment and prevention of disease, with a primary ef ....

United States , Kostenloser Wertpapierhandel , Brian John , Indications In Clinical Development , Skin Cancer Foundation , Company Investigational New Drug , Jupiter Wellness Inc , Drug Administration , Four Indications , Clinical Development , Jupiter Wellness , Patient Enrollment , Skin Cancer , Actinic Keratosis , Recruitment Started , First Degree Burns , Eczema Phase , Investigational New Drug , Herpes Cold Sores Expected , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , பிரையன் ஜான் , தோல் புற்றுநோய் அடித்தளம் , வியாழன் ஆரோக்கியம் இன்க் , மருத்துவ வளர்ச்சி , வியாழன் ஆரோக்கியம் ,

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

United States , Brian John , Indications In Clinical Development , Skin Cancer Foundation , Company Investigational New Drug , Jupiter Wellness Inc , Drug Administration , Four Indications , Clinical Development , Jupiter Wellness , Patient Enrollment , Skin Cancer , Actinic Keratosis , Recruitment Started , First Degree Burns , Eczema Phase , Investigational New Drug , Herpes Cold Sores Expected , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , பிரையன் ஜான் , தோல் புற்றுநோய் அடித்தளம் , வியாழன் ஆரோக்கியம் இன்க் , மருத்துவ வளர்ச்சி , வியாழன் ஆரோக்கியம் , நோயாளி சேர்க்கை ,